Enteral nutritional product for patients undergoing radiation therapy and/or chemotherapy
US5547927A · kind A · utility
23Cited by
6References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 1993 |
| Grant date | Aug 20, 1996 |
| Priority date | — |
| Expiry date | May 28, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An enteral nutritional product has been formulated for persons who are currently undergoing radiation therapy and/or chemotherapy. The nutritional product has a protein system which includes a soy protein hydrolysate. The nutritional product is very low in folic acid, contains .beta.-carotene, and has a ratio of n-6 to n-3 fatty acids that is in the range of about 1.3:1 to 2.5:1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.